Advanced Genomics – Key Disruptive Forces to Transform Health and Wellness

Pages: 33 Published: September 12, 2022 Report Code: GDDT-FT-S016

Advances in genomics have revolutionized approaches to healthcare and precision medicine. The major drivers of genomics include personalized medicine, customized genetic counseling, genetic predisposition identification, accurate disease diagnosis, disease prevention, and optimized treatments.

Advances in genomics are significantly reducing the cost of genome sequencing. Genomic techniques not only help in understanding the nature of the virus to trace its potential origins but also aids in tracking disease outbreaks.

The Advanced Genomics FutureTech Series report categorizes 30+ disruptive forces in genomics as emerging, accelerating, and maturing innovation areas based on their rate of growth in innovation. It also casts light on key market activities in emerging innovation areas, such as Chimeric antigen receptor (CAR-T) cell therapy, nanopore sequencing, comparative genomic hybridization (CGH), and genetic data encryption on the patent grants, key geographies, major players, and recent developments.

Key Sectors Impacted by Genomics

Some of the key sectors in genomics by the news, deals and company filings are healthcare, technology, media & telecom, government & non-profit organizations, consumer, agriculture & forestry, chemicals, and financial services.

Innovation Area Definitions and Patent Trends

Emerging: Single-molecule real-time (SMRT) sequencing is a technology that enables sequencing from individual DNA molecules without the need for amplification and fragmentation of the target sequence.

Accelerating: Mutation tracking is the process of detecting any alteration in the nucleic acid sequence of the genome of an organism that may or may not alter the phenotype.

Maturing: Herbicide resistant crops (HRC) are designed to tolerate specific broad-spectrum herbicides, which can kill the surrounding weeds but leave the cultivated crop intact.

Emerging, Accelerating, and Maturing Innovation Areas with Disruptive Potential in Genomics

Emerging, Accelerating, and Maturing Innovation Areas with Disruptive Potential in Genomics

For more innovation area insights, download a free report sample

Emerging Innovation Areas in Genomics

  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Non-Coding DNA/RNA Therapy
  • Comparative Genomic Hybridization (CGH)
  • Nanoball Sequencing
  • Single Molecule Sequencing
  • Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Genetic Data Encryption

Advanced Genomics FutureTech Series Report Overview

Key Sectors Healthcare, Technology, Media & Telecom, Government & Non-Profit Organizations, Consumer, Agriculture & Forestry, Chemicals, and Financial Services
Major Drivers Personalized Medicine, Customized Genetic Counseling, Genetic Predisposition Identification, Accurate Disease Diagnosis, Disease Prevention, and Optimized Treatments
Emerging Innovation Areas Nanopore Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Non-Coding DNA/RNA Therapy, Comparative Genomic Hybridization (CGH), Nanoball Sequencing, Single Molecule Sequencing, Chimeric Antigen Receptor (CAR-T) Cell Therapy, and Genetic Data Encryption

Scope

  • Key disruptive forces in genomics – presents the major drivers, impact, top sectors impacted by genomics, and emerging, accelerating, and maturing innovation areas with disruptive potential in genomics.
  • Emerging innovation areas – overview of select emerging innovation areas to capture their disruptive potential, innovation drivers, recent developments, patents trends, partnerships, and disruptive startups.
  • Outlook – Genomics technology innovation intensity (TII) forecast till 2025 vs an average of 35 trending technologies.

Reasons to Buy

GlobalData’s FutureTech Series Reports are aimed at capturing futuristic technologies which have the potential to disrupt tomorrow. These technologies are constantly changing, adapting, and progressing to enable a paradigm shift in our daily lives. The awareness, knowledge, and expertise of these topics help transform business models and strategic thinking with an in-depth understanding of megatrends that can directly influence patenting, collaboration, acquisition, and investment decisions.

Key Players

10X Genomics
Access
Adaptive Biotechnologies
Agilent Technologies
Annogen
Ascus Bioscience
Bayer
BGI Group
BioNTech
bluebird bio
Bluestar Genomics
BostonGene
Caribou Biosciences
CD Genomics
CHUV
Codexis
Congenica
Corteva
CRISPR Therapeutics
Dovetail Genomics
Editas Medicine
EXUMA Biotech
GeneCrypt
Genemind
Genetica
Genomics England
GenomSys
Google
Gritstone Bio
Guardant Health
Hamad Bin Khalifa University
HAYA Therapeutics
Helix OpCo
Human Longevity
IBM
Ideaya Biosciences
iLAC
Illumina
Immatics
Inbiomotion
Intellia Therapeutics
Johnson & Johnson
JumpCode Genomics
KeyGene
LabCorp
Legend Biotech
Macrogen
Mayo Clinic
MS Technologies
NantWorks
Natera
Novartis
Oncorus
Otsuka
Oxford Nanopore Technologies
PacBio
PathogenDx
Personalis
Philips
Precision Biosciences
ProKidney
Quantum-Si
Ravel
Recombinetics
Regeneron Pharmaceuticals
Robotic Biology Institute
Roche
Roswell Biotechnologies
Roswell Biotechnologies
Sangamo Therapeutics
Seqll
Seven Bridges Genomics
SNIPR Biome
SOHO Global Health
Sophia Genetics
Stoke Therapeutics
The Bristol-Myers Squibb
Thermo Fisher Scientific
TwinStrand Biosciences
Unitec
XenoTherapeutics

Table of Contents

Table of Contents

1. Disruptive forces in genomics – Major drivers, impact, top sectors impacted by genomics, S curve highlighting the emerging, accelerating, and maturing innovation areas, 3-year vs 1-year growth in patent grants for innovation areas, and innovation areas definitions, patent grants trend, and major patent filers.

2. Emerging innovation areas – the disruptive potential of key innovation areas as highlighted by the underlying data signals involving patents, recent developments, strategic partnerships, game-changing innovations, and leading market players.

3. Outlook – Genomics technology innovation intensity (TII) forecast till 2025 vs an average of 35 trending technologies.

Frequently Asked Questions

The major drivers of genomics include personalized medicine, customized genetic counseling, genetic predisposition identification, accurate disease diagnosis, disease prevention, and optimized treatments.

Single-molecule real-time (SMRT) sequencing is a technology that enables sequencing from individual DNA molecules without the need for amplification and fragmentation of the target sequence.

Some of the key sectors in genomics by the news, deals and company filings are healthcare, technology, media & telecom, government & non-profit organizations, consumer, agriculture & forestry, chemicals, and financial services.

The emerging innovation areas in genomics are nanopore sequencing, single-molecule real-time (SMRT) sequencing, non-coding DNA/RNA therapy, comparative genomic hybridization (CGH), nanoball sequencing, single molecule sequencing, chimeric antigen receptor (CAR-T) cell therapy, and genetic data encryption.

$1,495

Can be used by individual purchaser only

$2,990

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Still undecided about purchasing this report?

Enquire Before Buying

Request a Free Sample

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods